nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—GRIN2B—epilepsy syndrome	0.0916	0.492	CbGaD
Haloperidol—schizophrenia—Lamotrigine—epilepsy syndrome	0.0818	0.332	CpDpCtD
Haloperidol—Mazindol—Midazolam—epilepsy syndrome	0.0725	0.529	CrCrCtD
Haloperidol—Mazindol—Diazepam—epilepsy syndrome	0.0646	0.471	CrCrCtD
Haloperidol—schizophrenia—Carbamazepine—epilepsy syndrome	0.062	0.252	CpDpCtD
Haloperidol—schizophrenia—Valproic Acid—epilepsy syndrome	0.0527	0.214	CpDpCtD
Haloperidol—GRIN2B—Felbamate—epilepsy syndrome	0.05	0.196	CbGbCtD
Haloperidol—schizophrenia—Clonazepam—epilepsy syndrome	0.0495	0.201	CpDpCtD
Haloperidol—CYP2C19—epilepsy syndrome	0.0307	0.165	CbGaD
Haloperidol—HTR2A—epilepsy syndrome	0.0249	0.134	CbGaD
Haloperidol—CYP2D6—epilepsy syndrome	0.0227	0.122	CbGaD
Haloperidol—ABCB1—epilepsy syndrome	0.0162	0.0872	CbGaD
Haloperidol—UGT1A9—Propofol—epilepsy syndrome	0.0114	0.0448	CbGbCtD
Haloperidol—UGT1A9—Valproic Acid—epilepsy syndrome	0.00813	0.032	CbGbCtD
Haloperidol—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0054	0.0212	CbGbCtD
Haloperidol—CYP1A1—Propofol—epilepsy syndrome	0.00473	0.0186	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00452	0.0178	CbGbCtD
Haloperidol—CYP3A7—Carbamazepine—epilepsy syndrome	0.00452	0.0178	CbGbCtD
Haloperidol—CYP1A1—Phenobarbital—epilepsy syndrome	0.00452	0.0178	CbGbCtD
Haloperidol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00436	0.0171	CbGbCtD
Haloperidol—CYP3A7—Phenytoin—epilepsy syndrome	0.00406	0.016	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00406	0.016	CbGbCtD
Haloperidol—CYP2C19—Felbamate—epilepsy syndrome	0.00405	0.0159	CbGbCtD
Haloperidol—CYP2C19—Trimethadione—epilepsy syndrome	0.00405	0.0159	CbGbCtD
Haloperidol—ABCB1—Levetiracetam—epilepsy syndrome	0.00384	0.0151	CbGbCtD
Haloperidol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00381	0.015	CbGbCtD
Haloperidol—CYP3A7—Phenobarbital—epilepsy syndrome	0.00361	0.0142	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00361	0.0142	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00356	0.014	CbGbCtD
Haloperidol—CYP3A7—Midazolam—epilepsy syndrome	0.00356	0.014	CbGbCtD
Haloperidol—CYP3A7—Diazepam—epilepsy syndrome	0.00343	0.0135	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00343	0.0135	CbGbCtD
Haloperidol—CYP3A5—Carbamazepine—epilepsy syndrome	0.00339	0.0133	CbGbCtD
Haloperidol—CYP2C9—Trimethadione—epilepsy syndrome	0.00337	0.0132	CbGbCtD
Haloperidol—CYP2C19—Clobazam—epilepsy syndrome	0.0033	0.013	CbGbCtD
Haloperidol—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00317	0.0125	CbGbCtD
Haloperidol—CYP3A5—Phenytoin—epilepsy syndrome	0.00304	0.012	CbGbCtD
Haloperidol—HTR1D—meninx—epilepsy syndrome	0.00278	0.0924	CbGeAlD
Haloperidol—CYP2C19—Carbamazepine—epilepsy syndrome	0.00274	0.0108	CbGbCtD
Haloperidol—CYP3A5—Phenobarbital—epilepsy syndrome	0.00271	0.0107	CbGbCtD
Haloperidol—CYP3A5—Midazolam—epilepsy syndrome	0.00267	0.0105	CbGbCtD
Haloperidol—ABCB1—Clobazam—epilepsy syndrome	0.00266	0.0105	CbGbCtD
Haloperidol—CYP3A5—Diazepam—epilepsy syndrome	0.00257	0.0101	CbGbCtD
Haloperidol—ABCB1—Lamotrigine—epilepsy syndrome	0.00256	0.0101	CbGbCtD
Haloperidol—CYP2C19—Primidone—epilepsy syndrome	0.00255	0.01	CbGbCtD
Haloperidol—CYP1A2—Carbamazepine—epilepsy syndrome	0.00252	0.00993	CbGbCtD
Haloperidol—CYP2C19—Phenytoin—epilepsy syndrome	0.00245	0.00965	CbGbCtD
Haloperidol—CYP1A2—Primidone—epilepsy syndrome	0.00236	0.00927	CbGbCtD
Haloperidol—CYP2C19—Propofol—epilepsy syndrome	0.00229	0.009	CbGbCtD
Haloperidol—CYP2C9—Carbamazepine—epilepsy syndrome	0.00227	0.00895	CbGbCtD
Haloperidol—ABCB1—Carbamazepine—epilepsy syndrome	0.00221	0.00868	CbGbCtD
Haloperidol—CYP2C19—Phenobarbital—epilepsy syndrome	0.00219	0.0086	CbGbCtD
Haloperidol—CYP2C9—Primidone—epilepsy syndrome	0.00212	0.00835	CbGbCtD
Haloperidol—CYP1A2—Propofol—epilepsy syndrome	0.00211	0.00831	CbGbCtD
Haloperidol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00211	0.00828	CbGbCtD
Haloperidol—CYP2C19—Diazepam—epilepsy syndrome	0.00207	0.00815	CbGbCtD
Haloperidol—CYP2C9—Phenytoin—epilepsy syndrome	0.00204	0.00802	CbGbCtD
Haloperidol—CYP3A5—Valproic Acid—epilepsy syndrome	0.00203	0.00797	CbGbCtD
Haloperidol—CYP2C19—Zonisamide—epilepsy syndrome	0.00202	0.00796	CbGbCtD
Haloperidol—CYP1A2—Phenobarbital—epilepsy syndrome	0.00202	0.00794	CbGbCtD
Haloperidol—ABCB1—Phenytoin—epilepsy syndrome	0.00198	0.00779	CbGbCtD
Haloperidol—CYP3A4—Trimethadione—epilepsy syndrome	0.00196	0.0077	CbGbCtD
Haloperidol—CYP3A4—Felbamate—epilepsy syndrome	0.00196	0.0077	CbGbCtD
Haloperidol—CYP1A2—Diazepam—epilepsy syndrome	0.00191	0.00752	CbGbCtD
Haloperidol—CYP2C9—Propofol—epilepsy syndrome	0.0019	0.00748	CbGbCtD
Haloperidol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00184	0.00724	CbGbCtD
Haloperidol—CYP2C9—Phenobarbital—epilepsy syndrome	0.00182	0.00715	CbGbCtD
Haloperidol—ABCB1—Phenobarbital—epilepsy syndrome	0.00176	0.00694	CbGbCtD
Haloperidol—ABCB1—Midazolam—epilepsy syndrome	0.00174	0.00684	CbGbCtD
Haloperidol—CYP2D6—Propofol—epilepsy syndrome	0.00174	0.00684	CbGbCtD
Haloperidol—CYP2C9—Diazepam—epilepsy syndrome	0.00172	0.00678	CbGbCtD
Haloperidol—ABCB1—Diazepam—epilepsy syndrome	0.00167	0.00658	CbGbCtD
Haloperidol—CYP3A4—Clonazepam—epilepsy syndrome	0.00166	0.00655	CbGbCtD
Haloperidol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00163	0.00643	CbGbCtD
Haloperidol—CYP3A4—Clobazam—epilepsy syndrome	0.0016	0.00628	CbGbCtD
Haloperidol—CYP1A2—Valproic Acid—epilepsy syndrome	0.00151	0.00593	CbGbCtD
Haloperidol—HTR2A—phrenic nerve—epilepsy syndrome	0.0015	0.0497	CbGeAlD
Haloperidol—CYP2C19—Topiramate—epilepsy syndrome	0.00147	0.0058	CbGbCtD
Haloperidol—CYP2C9—Valproic Acid—epilepsy syndrome	0.00136	0.00534	CbGbCtD
Haloperidol—CYP3A4—Rufinamide—epilepsy syndrome	0.00136	0.00534	CbGbCtD
Haloperidol—GRIN2B—telencephalic ventricle—epilepsy syndrome	0.00136	0.045	CbGeAlD
Haloperidol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00132	0.0052	CbGbCtD
Haloperidol—CYP3A4—Primidone—epilepsy syndrome	0.00123	0.00486	CbGbCtD
Haloperidol—CYP3A4—Phenytoin—epilepsy syndrome	0.00119	0.00467	CbGbCtD
Haloperidol—DRD3—telencephalic ventricle—epilepsy syndrome	0.00114	0.0377	CbGeAlD
Haloperidol—CYP3A4—Propofol—epilepsy syndrome	0.00111	0.00435	CbGbCtD
Haloperidol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00106	0.00416	CbGbCtD
Haloperidol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00106	0.00416	CbGbCtD
Haloperidol—CYP3A4—Midazolam—epilepsy syndrome	0.00104	0.0041	CbGbCtD
Haloperidol—CYP3A4—Diazepam—epilepsy syndrome	0.001	0.00394	CbGbCtD
Haloperidol—CYP3A4—Zonisamide—epilepsy syndrome	0.000978	0.00385	CbGbCtD
Haloperidol—GRIN2B—ganglion—epilepsy syndrome	0.000844	0.028	CbGeAlD
Haloperidol—DRD1—telencephalic ventricle—epilepsy syndrome	0.000814	0.027	CbGeAlD
Haloperidol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00079	0.00311	CbGbCtD
Haloperidol—CYP3A4—Topiramate—epilepsy syndrome	0.000713	0.0028	CbGbCtD
Haloperidol—HTR2A—locus ceruleus—epilepsy syndrome	0.000669	0.0222	CbGeAlD
Haloperidol—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000659	0.0219	CbGeAlD
Haloperidol—GRIN2B—hindbrain—epilepsy syndrome	0.00064	0.0212	CbGeAlD
Haloperidol—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000638	0.0212	CbGeAlD
Haloperidol—HTR2A—cerebellar cortex—epilepsy syndrome	0.000545	0.0181	CbGeAlD
Haloperidol—HTR2A—vagus nerve—epilepsy syndrome	0.000512	0.017	CbGeAlD
Haloperidol—DRD1—ganglion—epilepsy syndrome	0.000506	0.0168	CbGeAlD
Haloperidol—DRD2—telencephalic ventricle—epilepsy syndrome	0.000481	0.0159	CbGeAlD
Haloperidol—HTR1B—ganglion—epilepsy syndrome	0.00041	0.0136	CbGeAlD
Haloperidol—HTR1D—ganglion—epilepsy syndrome	0.000397	0.0132	CbGeAlD
Haloperidol—HTR2A—pons—epilepsy syndrome	0.000385	0.0128	CbGeAlD
Haloperidol—GRIN2B—brainstem—epilepsy syndrome	0.000367	0.0122	CbGeAlD
Haloperidol—HTR2A—autonomic nervous system—epilepsy syndrome	0.000355	0.0118	CbGeAlD
Haloperidol—GRIN2B—forebrain—epilepsy syndrome	0.000354	0.0117	CbGeAlD
Haloperidol—CBR1—Niclosamide—Clonazepam—epilepsy syndrome	0.00033	0.505	CbGdCrCtD
Haloperidol—GRIN2B—telencephalon—epilepsy syndrome	0.000326	0.0108	CbGeAlD
Haloperidol—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.000324	0.495	CbGdCrCtD
Haloperidol—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000317	0.0105	CbGeAlD
Haloperidol—DRD2—ganglion—epilepsy syndrome	0.000299	0.00993	CbGeAlD
Haloperidol—CBR1—forebrain—epilepsy syndrome	0.000263	0.00871	CbGeAlD
Haloperidol—Loperamide—CACNA1A—epilepsy syndrome	0.000245	0.142	CrCbGaD
Haloperidol—Anileridine—OPRM1—epilepsy syndrome	0.000244	0.142	CrCbGaD
Haloperidol—CBR1—telencephalon—epilepsy syndrome	0.000241	0.00801	CbGeAlD
Haloperidol—GRIN2B—spinal cord—epilepsy syndrome	0.000228	0.00757	CbGeAlD
Haloperidol—DRD2—hindbrain—epilepsy syndrome	0.000227	0.00753	CbGeAlD
Haloperidol—DRD1—brainstem—epilepsy syndrome	0.00022	0.0073	CbGeAlD
Haloperidol—H1F0—forebrain—epilepsy syndrome	0.000215	0.00714	CbGeAlD
Haloperidol—DRD1—forebrain—epilepsy syndrome	0.000212	0.00705	CbGeAlD
Haloperidol—GRIN2B—head—epilepsy syndrome	0.000203	0.00673	CbGeAlD
Haloperidol—H1F0—telencephalon—epilepsy syndrome	0.000198	0.00656	CbGeAlD
Haloperidol—HTR2A—ganglion—epilepsy syndrome	0.000197	0.00655	CbGeAlD
Haloperidol—DRD1—telencephalon—epilepsy syndrome	0.000195	0.00648	CbGeAlD
Haloperidol—GRIN2B—nervous system—epilepsy syndrome	0.000192	0.00638	CbGeAlD
Haloperidol—CBR1—medulla oblongata—epilepsy syndrome	0.00019	0.00629	CbGeAlD
Haloperidol—GRIN2B—central nervous system—epilepsy syndrome	0.000185	0.00614	CbGeAlD
Haloperidol—GRIN2B—cerebellum—epilepsy syndrome	0.000181	0.006	CbGeAlD
Haloperidol—HTR1B—brainstem—epilepsy syndrome	0.000178	0.00592	CbGeAlD
Haloperidol—DRD4—brain—epilepsy syndrome	0.000175	0.00581	CbGeAlD
Haloperidol—CBR1—midbrain—epilepsy syndrome	0.000173	0.00575	CbGeAlD
Haloperidol—HTR1D—brainstem—epilepsy syndrome	0.000173	0.00573	CbGeAlD
Haloperidol—HTR1B—forebrain—epilepsy syndrome	0.000172	0.00571	CbGeAlD
Haloperidol—Loperamide—POMC—epilepsy syndrome	0.00017	0.0987	CrCbGaD
Haloperidol—DRD3—head—epilepsy syndrome	0.00017	0.00564	CbGeAlD
Haloperidol—CBR1—spinal cord—epilepsy syndrome	0.000169	0.00561	CbGeAlD
Haloperidol—HTR1D—forebrain—epilepsy syndrome	0.000167	0.00553	CbGeAlD
Haloperidol—DRD3—nervous system—epilepsy syndrome	0.000161	0.00534	CbGeAlD
Haloperidol—HTR1B—telencephalon—epilepsy syndrome	0.000158	0.00525	CbGeAlD
Haloperidol—H1F0—medulla oblongata—epilepsy syndrome	0.000155	0.00516	CbGeAlD
Haloperidol—DRD3—central nervous system—epilepsy syndrome	0.000155	0.00514	CbGeAlD
Haloperidol—HTR2B—forebrain—epilepsy syndrome	0.000155	0.00514	CbGeAlD
Haloperidol—HTR1D—telencephalon—epilepsy syndrome	0.000153	0.00508	CbGeAlD
Haloperidol—CBR1—head—epilepsy syndrome	0.00015	0.00499	CbGeAlD
Haloperidol—HTR2A—hindbrain—epilepsy syndrome	0.00015	0.00496	CbGeAlD
Haloperidol—GRIN2B—brain—epilepsy syndrome	0.000147	0.00487	CbGeAlD
Haloperidol—SIGMAR1—telencephalon—epilepsy syndrome	0.000143	0.00474	CbGeAlD
Haloperidol—HTR2B—telencephalon—epilepsy syndrome	0.000143	0.00473	CbGeAlD
Haloperidol—CBR1—nervous system—epilepsy syndrome	0.000143	0.00473	CbGeAlD
Haloperidol—H1F0—midbrain—epilepsy syndrome	0.000142	0.00471	CbGeAlD
Haloperidol—DRD1—midbrain—epilepsy syndrome	0.00014	0.00465	CbGeAlD
Haloperidol—H1F0—spinal cord—epilepsy syndrome	0.000139	0.0046	CbGeAlD
Haloperidol—CBR1—central nervous system—epilepsy syndrome	0.000137	0.00455	CbGeAlD
Haloperidol—CYP2D6—hindbrain—epilepsy syndrome	0.000136	0.00452	CbGeAlD
Haloperidol—CBR1—cerebellum—epilepsy syndrome	0.000134	0.00445	CbGeAlD
Haloperidol—DRD2—brainstem—epilepsy syndrome	0.00013	0.00431	CbGeAlD
Haloperidol—DRD2—forebrain—epilepsy syndrome	0.000126	0.00416	CbGeAlD
Haloperidol—KCNH2—forebrain—epilepsy syndrome	0.000124	0.0041	CbGeAlD
Haloperidol—H1F0—head—epilepsy syndrome	0.000123	0.00409	CbGeAlD
Haloperidol—DRD3—brain—epilepsy syndrome	0.000123	0.00408	CbGeAlD
Haloperidol—DRD1—head—epilepsy syndrome	0.000122	0.00404	CbGeAlD
Haloperidol—H1F0—nervous system—epilepsy syndrome	0.000117	0.00387	CbGeAlD
Haloperidol—DRD2—telencephalon—epilepsy syndrome	0.000115	0.00383	CbGeAlD
Haloperidol—DRD1—nervous system—epilepsy syndrome	0.000115	0.00383	CbGeAlD
Haloperidol—KCNH2—telencephalon—epilepsy syndrome	0.000114	0.00377	CbGeAlD
Haloperidol—HTR1B—midbrain—epilepsy syndrome	0.000114	0.00377	CbGeAlD
Haloperidol—H1F0—central nervous system—epilepsy syndrome	0.000112	0.00373	CbGeAlD
Haloperidol—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000112	0.00372	CbGeAlD
Haloperidol—DRD1—central nervous system—epilepsy syndrome	0.000111	0.00368	CbGeAlD
Haloperidol—HTR1B—spinal cord—epilepsy syndrome	0.000111	0.00368	CbGeAlD
Haloperidol—HTR1D—midbrain—epilepsy syndrome	0.00011	0.00365	CbGeAlD
Haloperidol—H1F0—cerebellum—epilepsy syndrome	0.00011	0.00365	CbGeAlD
Haloperidol—CBR1—brain—epilepsy syndrome	0.000109	0.00361	CbGeAlD
Haloperidol—Sertindole—ADRA2A—epilepsy syndrome	0.000104	0.0604	CrCbGaD
Haloperidol—SIGMAR1—midbrain—epilepsy syndrome	0.000103	0.0034	CbGeAlD
Haloperidol—SIGMAR1—spinal cord—epilepsy syndrome	0.0001	0.00332	CbGeAlD
Haloperidol—Moclobemide—CYP2C19—epilepsy syndrome	9.93e-05	0.0576	CrCbGaD
Haloperidol—HRH1—forebrain—epilepsy syndrome	9.91e-05	0.00329	CbGeAlD
Haloperidol—HTR1B—head—epilepsy syndrome	9.86e-05	0.00327	CbGeAlD
Haloperidol—Loperamide—OPRD1—epilepsy syndrome	9.58e-05	0.0556	CrCbGaD
Haloperidol—HTR1D—head—epilepsy syndrome	9.54e-05	0.00317	CbGeAlD
Haloperidol—Droperidol—HTR2A—epilepsy syndrome	9.47e-05	0.0549	CrCbGaD
Haloperidol—HTR1B—nervous system—epilepsy syndrome	9.35e-05	0.0031	CbGeAlD
Haloperidol—HRH1—telencephalon—epilepsy syndrome	9.12e-05	0.00302	CbGeAlD
Haloperidol—HTR1D—nervous system—epilepsy syndrome	9.05e-05	0.003	CbGeAlD
Haloperidol—HTR1B—central nervous system—epilepsy syndrome	9e-05	0.00298	CbGeAlD
Haloperidol—KCNH2—medulla oblongata—epilepsy syndrome	8.94e-05	0.00296	CbGeAlD
Haloperidol—H1F0—brain—epilepsy syndrome	8.93e-05	0.00296	CbGeAlD
Haloperidol—HTR2B—head—epilepsy syndrome	8.88e-05	0.00294	CbGeAlD
Haloperidol—DRD1—brain—epilepsy syndrome	8.82e-05	0.00292	CbGeAlD
Haloperidol—HTR1D—central nervous system—epilepsy syndrome	8.71e-05	0.00289	CbGeAlD
Haloperidol—HTR2A—brainstem—epilepsy syndrome	8.58e-05	0.00285	CbGeAlD
Haloperidol—Fluspirilene—ADRA2A—epilepsy syndrome	8.48e-05	0.0492	CrCbGaD
Haloperidol—HTR2B—nervous system—epilepsy syndrome	8.42e-05	0.00279	CbGeAlD
Haloperidol—DRD2—midbrain—epilepsy syndrome	8.29e-05	0.00275	CbGeAlD
Haloperidol—HTR2A—forebrain—epilepsy syndrome	8.28e-05	0.00275	CbGeAlD
Haloperidol—KCNH2—midbrain—epilepsy syndrome	8.17e-05	0.00271	CbGeAlD
Haloperidol—HTR2B—central nervous system—epilepsy syndrome	8.1e-05	0.00269	CbGeAlD
Haloperidol—KCNH2—spinal cord—epilepsy syndrome	7.97e-05	0.00264	CbGeAlD
Haloperidol—SIGMAR1—cerebellum—epilepsy syndrome	7.94e-05	0.00263	CbGeAlD
Haloperidol—Mazindol—SLC6A4—epilepsy syndrome	7.94e-05	0.0461	CrCbGaD
Haloperidol—Sertindole—SLC6A4—epilepsy syndrome	7.94e-05	0.0461	CrCbGaD
Haloperidol—CYP2D6—brainstem—epilepsy syndrome	7.82e-05	0.00259	CbGeAlD
Haloperidol—HTR2A—telencephalon—epilepsy syndrome	7.61e-05	0.00253	CbGeAlD
Haloperidol—CYP2D6—forebrain—epilepsy syndrome	7.54e-05	0.0025	CbGeAlD
Haloperidol—Moclobemide—CYP2D6—epilepsy syndrome	7.36e-05	0.0427	CrCbGaD
Haloperidol—Loperamide—OPRM1—epilepsy syndrome	7.33e-05	0.0425	CrCbGaD
Haloperidol—DRD2—head—epilepsy syndrome	7.19e-05	0.00238	CbGeAlD
Haloperidol—HTR1B—brain—epilepsy syndrome	7.14e-05	0.00237	CbGeAlD
Haloperidol—KCNH2—head—epilepsy syndrome	7.08e-05	0.00235	CbGeAlD
Haloperidol—CYP2D6—telencephalon—epilepsy syndrome	6.94e-05	0.0023	CbGeAlD
Haloperidol—HTR1D—brain—epilepsy syndrome	6.92e-05	0.00229	CbGeAlD
Haloperidol—DRD2—nervous system—epilepsy syndrome	6.81e-05	0.00226	CbGeAlD
Haloperidol—KCNH2—nervous system—epilepsy syndrome	6.71e-05	0.00223	CbGeAlD
Haloperidol—DRD2—central nervous system—epilepsy syndrome	6.56e-05	0.00218	CbGeAlD
Haloperidol—Fluspirilene—SLC6A4—epilepsy syndrome	6.47e-05	0.0375	CrCbGaD
Haloperidol—KCNH2—central nervous system—epilepsy syndrome	6.46e-05	0.00214	CbGeAlD
Haloperidol—SIGMAR1—brain—epilepsy syndrome	6.45e-05	0.00214	CbGeAlD
Haloperidol—HTR2B—brain—epilepsy syndrome	6.43e-05	0.00213	CbGeAlD
Haloperidol—DRD2—cerebellum—epilepsy syndrome	6.41e-05	0.00213	CbGeAlD
Haloperidol—KCNH2—cerebellum—epilepsy syndrome	6.32e-05	0.0021	CbGeAlD
Haloperidol—Sertindole—HTR2A—epilepsy syndrome	6.1e-05	0.0354	CrCbGaD
Haloperidol—HTR2A—medulla oblongata—epilepsy syndrome	5.98e-05	0.00198	CbGeAlD
Haloperidol—CYP1A1—head—epilepsy syndrome	5.98e-05	0.00198	CbGeAlD
Haloperidol—HRH1—head—epilepsy syndrome	5.68e-05	0.00188	CbGeAlD
Haloperidol—CYP1A1—nervous system—epilepsy syndrome	5.67e-05	0.00188	CbGeAlD
Haloperidol—Sertindole—CYP2D6—epilepsy syndrome	5.58e-05	0.0324	CrCbGaD
Haloperidol—HTR2A—midbrain—epilepsy syndrome	5.47e-05	0.00181	CbGeAlD
Haloperidol—CYP1A1—central nervous system—epilepsy syndrome	5.46e-05	0.00181	CbGeAlD
Haloperidol—ABCB1—forebrain—epilepsy syndrome	5.43e-05	0.0018	CbGeAlD
Haloperidol—HRH1—nervous system—epilepsy syndrome	5.38e-05	0.00179	CbGeAlD
Haloperidol—HTR2A—spinal cord—epilepsy syndrome	5.33e-05	0.00177	CbGeAlD
Haloperidol—DRD2—brain—epilepsy syndrome	5.21e-05	0.00173	CbGeAlD
Haloperidol—HRH1—central nervous system—epilepsy syndrome	5.18e-05	0.00172	CbGeAlD
Haloperidol—KCNH2—brain—epilepsy syndrome	5.13e-05	0.0017	CbGeAlD
Haloperidol—ABCB1—telencephalon—epilepsy syndrome	4.99e-05	0.00165	CbGeAlD
Haloperidol—Fluspirilene—HTR2A—epilepsy syndrome	4.97e-05	0.0289	CrCbGaD
Haloperidol—HTR2A—head—epilepsy syndrome	4.74e-05	0.00157	CbGeAlD
Haloperidol—HTR2A—nervous system—epilepsy syndrome	4.49e-05	0.00149	CbGeAlD
Haloperidol—CYP1A1—brain—epilepsy syndrome	4.33e-05	0.00144	CbGeAlD
Haloperidol—HTR2A—central nervous system—epilepsy syndrome	4.33e-05	0.00144	CbGeAlD
Haloperidol—CYP2D6—head—epilepsy syndrome	4.32e-05	0.00143	CbGeAlD
Haloperidol—HTR2A—cerebellum—epilepsy syndrome	4.23e-05	0.0014	CbGeAlD
Haloperidol—CYP3A4—nervous system—epilepsy syndrome	4.16e-05	0.00138	CbGeAlD
Haloperidol—HRH1—brain—epilepsy syndrome	4.11e-05	0.00136	CbGeAlD
Haloperidol—CYP2D6—nervous system—epilepsy syndrome	4.09e-05	0.00136	CbGeAlD
Haloperidol—CYP3A4—central nervous system—epilepsy syndrome	4.01e-05	0.00133	CbGeAlD
Haloperidol—CYP2D6—central nervous system—epilepsy syndrome	3.94e-05	0.00131	CbGeAlD
Haloperidol—ABCB1—medulla oblongata—epilepsy syndrome	3.92e-05	0.0013	CbGeAlD
Haloperidol—CYP2D6—cerebellum—epilepsy syndrome	3.85e-05	0.00128	CbGeAlD
Haloperidol—ABCB1—midbrain—epilepsy syndrome	3.58e-05	0.00119	CbGeAlD
Haloperidol—ABCB1—spinal cord—epilepsy syndrome	3.5e-05	0.00116	CbGeAlD
Haloperidol—HTR2A—brain—epilepsy syndrome	3.44e-05	0.00114	CbGeAlD
Haloperidol—CYP2D6—brain—epilepsy syndrome	3.13e-05	0.00104	CbGeAlD
Haloperidol—ABCB1—head—epilepsy syndrome	3.11e-05	0.00103	CbGeAlD
Haloperidol—ABCB1—nervous system—epilepsy syndrome	2.95e-05	0.000977	CbGeAlD
Haloperidol—Loperamide—CYP2D6—epilepsy syndrome	2.84e-05	0.0165	CrCbGaD
Haloperidol—ABCB1—central nervous system—epilepsy syndrome	2.84e-05	0.000941	CbGeAlD
Haloperidol—ABCB1—cerebellum—epilepsy syndrome	2.77e-05	0.000919	CbGeAlD
Haloperidol—Rash—Levetiracetam—epilepsy syndrome	2.32e-05	0.000259	CcSEcCtD
Haloperidol—Anaemia—Pregabalin—epilepsy syndrome	2.32e-05	0.000259	CcSEcCtD
Haloperidol—Dermatitis—Levetiracetam—epilepsy syndrome	2.31e-05	0.000259	CcSEcCtD
Haloperidol—Mental disorder—Gabapentin—epilepsy syndrome	2.31e-05	0.000259	CcSEcCtD
Haloperidol—Agranulocytosis—Topiramate—epilepsy syndrome	2.31e-05	0.000258	CcSEcCtD
Haloperidol—Dry mouth—Valproic Acid—epilepsy syndrome	2.31e-05	0.000258	CcSEcCtD
Haloperidol—Agitation—Pregabalin—epilepsy syndrome	2.3e-05	0.000258	CcSEcCtD
Haloperidol—Headache—Levetiracetam—epilepsy syndrome	2.3e-05	0.000257	CcSEcCtD
Haloperidol—Malnutrition—Gabapentin—epilepsy syndrome	2.3e-05	0.000257	CcSEcCtD
Haloperidol—Hypersensitivity—Clonazepam—epilepsy syndrome	2.29e-05	0.000256	CcSEcCtD
Haloperidol—Dizziness—Vigabatrin—epilepsy syndrome	2.29e-05	0.000256	CcSEcCtD
Haloperidol—Confusional state—Valproic Acid—epilepsy syndrome	2.28e-05	0.000255	CcSEcCtD
Haloperidol—Pruritus—Zonisamide—epilepsy syndrome	2.28e-05	0.000255	CcSEcCtD
Haloperidol—Hypersensitivity—Phenytoin—epilepsy syndrome	2.27e-05	0.000254	CcSEcCtD
Haloperidol—Oedema—Valproic Acid—epilepsy syndrome	2.26e-05	0.000253	CcSEcCtD
Haloperidol—Anaphylactic shock—Valproic Acid—epilepsy syndrome	2.26e-05	0.000253	CcSEcCtD
Haloperidol—Urticaria—Lamotrigine—epilepsy syndrome	2.26e-05	0.000253	CcSEcCtD
Haloperidol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.26e-05	0.000253	CcSEcCtD
Haloperidol—Nausea—Propofol—epilepsy syndrome	2.26e-05	0.000253	CcSEcCtD
Haloperidol—Vomiting—Fosphenytoin—epilepsy syndrome	2.25e-05	0.000252	CcSEcCtD
Haloperidol—Diarrhoea—Felbamate—epilepsy syndrome	2.25e-05	0.000252	CcSEcCtD
Haloperidol—Vertigo—Pregabalin—epilepsy syndrome	2.25e-05	0.000252	CcSEcCtD
Haloperidol—ABCB1—brain—epilepsy syndrome	2.25e-05	0.000747	CbGeAlD
Haloperidol—Body temperature increased—Lamotrigine—epilepsy syndrome	2.25e-05	0.000252	CcSEcCtD
Haloperidol—Dizziness—Diazepam—epilepsy syndrome	2.25e-05	0.000252	CcSEcCtD
Haloperidol—Leukopenia—Pregabalin—epilepsy syndrome	2.24e-05	0.000251	CcSEcCtD
Haloperidol—Rash—Fosphenytoin—epilepsy syndrome	2.24e-05	0.00025	CcSEcCtD
Haloperidol—Dermatitis—Fosphenytoin—epilepsy syndrome	2.23e-05	0.00025	CcSEcCtD
Haloperidol—Headache—Fosphenytoin—epilepsy syndrome	2.22e-05	0.000248	CcSEcCtD
Haloperidol—Hepatitis—Topiramate—epilepsy syndrome	2.22e-05	0.000248	CcSEcCtD
Haloperidol—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.22e-05	0.000248	CcSEcCtD
Haloperidol—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.22e-05	0.000248	CcSEcCtD
Haloperidol—Nausea—Midazolam—epilepsy syndrome	2.21e-05	0.000247	CcSEcCtD
Haloperidol—Hallucination—Topiramate—epilepsy syndrome	2.21e-05	0.000247	CcSEcCtD
Haloperidol—Muscle spasms—Gabapentin—epilepsy syndrome	2.21e-05	0.000247	CcSEcCtD
Haloperidol—Tachycardia—Valproic Acid—epilepsy syndrome	2.21e-05	0.000247	CcSEcCtD
Haloperidol—Diarrhoea—Zonisamide—epilepsy syndrome	2.21e-05	0.000247	CcSEcCtD
Haloperidol—Pruritus—Clonazepam—epilepsy syndrome	2.2e-05	0.000246	CcSEcCtD
Haloperidol—Vomiting—Vigabatrin—epilepsy syndrome	2.2e-05	0.000246	CcSEcCtD
Haloperidol—Skin disorder—Valproic Acid—epilepsy syndrome	2.2e-05	0.000246	CcSEcCtD
Haloperidol—Urinary tract disorder—Topiramate—epilepsy syndrome	2.19e-05	0.000245	CcSEcCtD
Haloperidol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.19e-05	0.000245	CcSEcCtD
Haloperidol—Pruritus—Phenytoin—epilepsy syndrome	2.18e-05	0.000244	CcSEcCtD
Haloperidol—Connective tissue disorder—Topiramate—epilepsy syndrome	2.18e-05	0.000244	CcSEcCtD
Haloperidol—Nausea—Levetiracetam—epilepsy syndrome	2.18e-05	0.000244	CcSEcCtD
Haloperidol—Rash—Vigabatrin—epilepsy syndrome	2.18e-05	0.000244	CcSEcCtD
Haloperidol—Dizziness—Felbamate—epilepsy syndrome	2.18e-05	0.000244	CcSEcCtD
Haloperidol—Dermatitis—Vigabatrin—epilepsy syndrome	2.18e-05	0.000243	CcSEcCtD
Haloperidol—Urethral disorder—Topiramate—epilepsy syndrome	2.18e-05	0.000243	CcSEcCtD
Haloperidol—Pruritus—Oxcarbazepine—epilepsy syndrome	2.17e-05	0.000243	CcSEcCtD
Haloperidol—Convulsion—Pregabalin—epilepsy syndrome	2.17e-05	0.000243	CcSEcCtD
Haloperidol—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.17e-05	0.000243	CcSEcCtD
Haloperidol—Vision blurred—Gabapentin—epilepsy syndrome	2.17e-05	0.000242	CcSEcCtD
Haloperidol—Headache—Vigabatrin—epilepsy syndrome	2.17e-05	0.000242	CcSEcCtD
Haloperidol—Hypertension—Pregabalin—epilepsy syndrome	2.16e-05	0.000242	CcSEcCtD
Haloperidol—Vomiting—Diazepam—epilepsy syndrome	2.16e-05	0.000242	CcSEcCtD
Haloperidol—Anorexia—Valproic Acid—epilepsy syndrome	2.16e-05	0.000241	CcSEcCtD
Haloperidol—Tremor—Gabapentin—epilepsy syndrome	2.15e-05	0.000241	CcSEcCtD
Haloperidol—Rash—Diazepam—epilepsy syndrome	2.15e-05	0.00024	CcSEcCtD
Haloperidol—Dermatitis—Diazepam—epilepsy syndrome	2.14e-05	0.00024	CcSEcCtD
Haloperidol—Visual impairment—Topiramate—epilepsy syndrome	2.14e-05	0.000239	CcSEcCtD
Haloperidol—Dizziness—Zonisamide—epilepsy syndrome	2.13e-05	0.000238	CcSEcCtD
Haloperidol—Headache—Diazepam—epilepsy syndrome	2.13e-05	0.000238	CcSEcCtD
Haloperidol—Anxiety—Pregabalin—epilepsy syndrome	2.13e-05	0.000238	CcSEcCtD
Haloperidol—Diarrhoea—Clonazepam—epilepsy syndrome	2.13e-05	0.000238	CcSEcCtD
Haloperidol—Anaemia—Gabapentin—epilepsy syndrome	2.12e-05	0.000238	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.12e-05	0.000237	CcSEcCtD
Haloperidol—Hypotension—Valproic Acid—epilepsy syndrome	2.11e-05	0.000236	CcSEcCtD
Haloperidol—Agitation—Gabapentin—epilepsy syndrome	2.11e-05	0.000236	CcSEcCtD
Haloperidol—Diarrhoea—Phenytoin—epilepsy syndrome	2.11e-05	0.000236	CcSEcCtD
Haloperidol—Nausea—Fosphenytoin—epilepsy syndrome	2.11e-05	0.000236	CcSEcCtD
Haloperidol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.1e-05	0.000235	CcSEcCtD
Haloperidol—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.1e-05	0.000235	CcSEcCtD
Haloperidol—Vomiting—Felbamate—epilepsy syndrome	2.09e-05	0.000234	CcSEcCtD
Haloperidol—Dry mouth—Pregabalin—epilepsy syndrome	2.09e-05	0.000233	CcSEcCtD
Haloperidol—Pruritus—Carbamazepine—epilepsy syndrome	2.08e-05	0.000233	CcSEcCtD
Haloperidol—Rash—Felbamate—epilepsy syndrome	2.08e-05	0.000232	CcSEcCtD
Haloperidol—Eye disorder—Topiramate—epilepsy syndrome	2.08e-05	0.000232	CcSEcCtD
Haloperidol—Dermatitis—Felbamate—epilepsy syndrome	2.07e-05	0.000232	CcSEcCtD
Haloperidol—Vertigo—Gabapentin—epilepsy syndrome	2.06e-05	0.000231	CcSEcCtD
Haloperidol—Headache—Felbamate—epilepsy syndrome	2.06e-05	0.000231	CcSEcCtD
Haloperidol—Confusional state—Pregabalin—epilepsy syndrome	2.06e-05	0.000231	CcSEcCtD
Haloperidol—Cardiac disorder—Topiramate—epilepsy syndrome	2.06e-05	0.00023	CcSEcCtD
Haloperidol—Leukopenia—Gabapentin—epilepsy syndrome	2.06e-05	0.00023	CcSEcCtD
Haloperidol—Dizziness—Clonazepam—epilepsy syndrome	2.05e-05	0.00023	CcSEcCtD
Haloperidol—Nausea—Vigabatrin—epilepsy syndrome	2.05e-05	0.00023	CcSEcCtD
Haloperidol—Vomiting—Zonisamide—epilepsy syndrome	2.05e-05	0.000229	CcSEcCtD
Haloperidol—Insomnia—Valproic Acid—epilepsy syndrome	2.05e-05	0.000229	CcSEcCtD
Haloperidol—Oedema—Pregabalin—epilepsy syndrome	2.05e-05	0.000229	CcSEcCtD
Haloperidol—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.05e-05	0.000229	CcSEcCtD
Haloperidol—Dizziness—Phenytoin—epilepsy syndrome	2.04e-05	0.000228	CcSEcCtD
Haloperidol—Rash—Zonisamide—epilepsy syndrome	2.03e-05	0.000227	CcSEcCtD
Haloperidol—Dermatitis—Zonisamide—epilepsy syndrome	2.03e-05	0.000227	CcSEcCtD
Haloperidol—Dizziness—Oxcarbazepine—epilepsy syndrome	2.03e-05	0.000227	CcSEcCtD
Haloperidol—Loperamide—ABCB1—epilepsy syndrome	2.03e-05	0.0118	CrCbGaD
Haloperidol—Nausea—Diazepam—epilepsy syndrome	2.02e-05	0.000226	CcSEcCtD
Haloperidol—Headache—Zonisamide—epilepsy syndrome	2.02e-05	0.000226	CcSEcCtD
Haloperidol—Dyspnoea—Valproic Acid—epilepsy syndrome	2.02e-05	0.000226	CcSEcCtD
Haloperidol—Diarrhoea—Carbamazepine—epilepsy syndrome	2.02e-05	0.000225	CcSEcCtD
Haloperidol—Angiopathy—Topiramate—epilepsy syndrome	2.02e-05	0.000225	CcSEcCtD
Haloperidol—Pruritus—Lamotrigine—epilepsy syndrome	2.01e-05	0.000225	CcSEcCtD
Haloperidol—Somnolence—Valproic Acid—epilepsy syndrome	2.01e-05	0.000225	CcSEcCtD
Haloperidol—Immune system disorder—Topiramate—epilepsy syndrome	2.01e-05	0.000224	CcSEcCtD
Haloperidol—Nervous system disorder—Pregabalin—epilepsy syndrome	2.01e-05	0.000224	CcSEcCtD
Haloperidol—Thrombocytopenia—Pregabalin—epilepsy syndrome	2e-05	0.000224	CcSEcCtD
Haloperidol—Mediastinal disorder—Topiramate—epilepsy syndrome	2e-05	0.000224	CcSEcCtD
Haloperidol—Tachycardia—Pregabalin—epilepsy syndrome	2e-05	0.000223	CcSEcCtD
Haloperidol—Dyspepsia—Valproic Acid—epilepsy syndrome	1.99e-05	0.000223	CcSEcCtD
Haloperidol—Convulsion—Gabapentin—epilepsy syndrome	1.99e-05	0.000223	CcSEcCtD
Haloperidol—Skin disorder—Pregabalin—epilepsy syndrome	1.99e-05	0.000222	CcSEcCtD
Haloperidol—Hypertension—Gabapentin—epilepsy syndrome	1.98e-05	0.000222	CcSEcCtD
Haloperidol—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.98e-05	0.000221	CcSEcCtD
Haloperidol—Vomiting—Clonazepam—epilepsy syndrome	1.98e-05	0.000221	CcSEcCtD
Haloperidol—Decreased appetite—Valproic Acid—epilepsy syndrome	1.97e-05	0.00022	CcSEcCtD
Haloperidol—Alopecia—Topiramate—epilepsy syndrome	1.96e-05	0.000219	CcSEcCtD
Haloperidol—Vomiting—Phenytoin—epilepsy syndrome	1.96e-05	0.000219	CcSEcCtD
Haloperidol—Rash—Clonazepam—epilepsy syndrome	1.96e-05	0.000219	CcSEcCtD
Haloperidol—Dermatitis—Clonazepam—epilepsy syndrome	1.96e-05	0.000219	CcSEcCtD
Haloperidol—Nausea—Felbamate—epilepsy syndrome	1.96e-05	0.000219	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Vomiting—Oxcarbazepine—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Anxiety—Gabapentin—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Anorexia—Pregabalin—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Dizziness—Carbamazepine—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Diarrhoea—Lamotrigine—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Headache—Clonazepam—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Rash—Phenytoin—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Mental disorder—Topiramate—epilepsy syndrome	1.95e-05	0.000218	CcSEcCtD
Haloperidol—Dermatitis—Phenytoin—epilepsy syndrome	1.94e-05	0.000217	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.94e-05	0.000217	CcSEcCtD
Haloperidol—Rash—Oxcarbazepine—epilepsy syndrome	1.94e-05	0.000216	CcSEcCtD
Haloperidol—Constipation—Valproic Acid—epilepsy syndrome	1.93e-05	0.000216	CcSEcCtD
Haloperidol—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.93e-05	0.000216	CcSEcCtD
Haloperidol—Headache—Phenytoin—epilepsy syndrome	1.93e-05	0.000216	CcSEcCtD
Haloperidol—Malnutrition—Topiramate—epilepsy syndrome	1.93e-05	0.000216	CcSEcCtD
Haloperidol—Headache—Oxcarbazepine—epilepsy syndrome	1.92e-05	0.000215	CcSEcCtD
Haloperidol—Nausea—Zonisamide—epilepsy syndrome	1.92e-05	0.000214	CcSEcCtD
Haloperidol—Dry mouth—Gabapentin—epilepsy syndrome	1.91e-05	0.000214	CcSEcCtD
Haloperidol—Hypotension—Pregabalin—epilepsy syndrome	1.91e-05	0.000214	CcSEcCtD
Haloperidol—Confusional state—Gabapentin—epilepsy syndrome	1.89e-05	0.000211	CcSEcCtD
Haloperidol—Dizziness—Lamotrigine—epilepsy syndrome	1.88e-05	0.000211	CcSEcCtD
Haloperidol—Oedema—Gabapentin—epilepsy syndrome	1.88e-05	0.00021	CcSEcCtD
Haloperidol—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.88e-05	0.00021	CcSEcCtD
Haloperidol—Vomiting—Carbamazepine—epilepsy syndrome	1.87e-05	0.000209	CcSEcCtD
Haloperidol—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.86e-05	0.000208	CcSEcCtD
Haloperidol—Muscle spasms—Topiramate—epilepsy syndrome	1.86e-05	0.000208	CcSEcCtD
Haloperidol—Rash—Carbamazepine—epilepsy syndrome	1.86e-05	0.000208	CcSEcCtD
Haloperidol—Dermatitis—Carbamazepine—epilepsy syndrome	1.86e-05	0.000208	CcSEcCtD
Haloperidol—Insomnia—Pregabalin—epilepsy syndrome	1.85e-05	0.000207	CcSEcCtD
Haloperidol—Nausea—Clonazepam—epilepsy syndrome	1.85e-05	0.000206	CcSEcCtD
Haloperidol—Headache—Carbamazepine—epilepsy syndrome	1.85e-05	0.000206	CcSEcCtD
Haloperidol—Nervous system disorder—Gabapentin—epilepsy syndrome	1.84e-05	0.000206	CcSEcCtD
Haloperidol—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.84e-05	0.000205	CcSEcCtD
Haloperidol—Nausea—Phenytoin—epilepsy syndrome	1.83e-05	0.000205	CcSEcCtD
Haloperidol—Tachycardia—Gabapentin—epilepsy syndrome	1.83e-05	0.000205	CcSEcCtD
Haloperidol—Dyspnoea—Pregabalin—epilepsy syndrome	1.82e-05	0.000204	CcSEcCtD
Haloperidol—Nausea—Oxcarbazepine—epilepsy syndrome	1.82e-05	0.000204	CcSEcCtD
Haloperidol—Vision blurred—Topiramate—epilepsy syndrome	1.82e-05	0.000204	CcSEcCtD
Haloperidol—Skin disorder—Gabapentin—epilepsy syndrome	1.82e-05	0.000204	CcSEcCtD
Haloperidol—Somnolence—Pregabalin—epilepsy syndrome	1.82e-05	0.000203	CcSEcCtD
Haloperidol—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.81e-05	0.000203	CcSEcCtD
Haloperidol—Tremor—Topiramate—epilepsy syndrome	1.81e-05	0.000203	CcSEcCtD
Haloperidol—Vomiting—Lamotrigine—epilepsy syndrome	1.81e-05	0.000202	CcSEcCtD
Haloperidol—Urticaria—Valproic Acid—epilepsy syndrome	1.8e-05	0.000201	CcSEcCtD
Haloperidol—Rash—Lamotrigine—epilepsy syndrome	1.8e-05	0.000201	CcSEcCtD
Haloperidol—Dermatitis—Lamotrigine—epilepsy syndrome	1.79e-05	0.000201	CcSEcCtD
Haloperidol—Body temperature increased—Valproic Acid—epilepsy syndrome	1.79e-05	0.0002	CcSEcCtD
Haloperidol—Anorexia—Gabapentin—epilepsy syndrome	1.79e-05	0.0002	CcSEcCtD
Haloperidol—Anaemia—Topiramate—epilepsy syndrome	1.79e-05	0.0002	CcSEcCtD
Haloperidol—Headache—Lamotrigine—epilepsy syndrome	1.78e-05	0.000199	CcSEcCtD
Haloperidol—Decreased appetite—Pregabalin—epilepsy syndrome	1.78e-05	0.000199	CcSEcCtD
Haloperidol—Agitation—Topiramate—epilepsy syndrome	1.78e-05	0.000199	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.77e-05	0.000197	CcSEcCtD
Haloperidol—Hypotension—Gabapentin—epilepsy syndrome	1.75e-05	0.000196	CcSEcCtD
Haloperidol—Nausea—Carbamazepine—epilepsy syndrome	1.75e-05	0.000196	CcSEcCtD
Haloperidol—Constipation—Pregabalin—epilepsy syndrome	1.75e-05	0.000196	CcSEcCtD
Haloperidol—Vertigo—Topiramate—epilepsy syndrome	1.74e-05	0.000194	CcSEcCtD
Haloperidol—Leukopenia—Topiramate—epilepsy syndrome	1.73e-05	0.000194	CcSEcCtD
Haloperidol—Insomnia—Gabapentin—epilepsy syndrome	1.7e-05	0.00019	CcSEcCtD
Haloperidol—Nausea—Lamotrigine—epilepsy syndrome	1.69e-05	0.000189	CcSEcCtD
Haloperidol—Feeling abnormal—Pregabalin—epilepsy syndrome	1.69e-05	0.000188	CcSEcCtD
Haloperidol—Convulsion—Topiramate—epilepsy syndrome	1.68e-05	0.000187	CcSEcCtD
Haloperidol—Dyspnoea—Gabapentin—epilepsy syndrome	1.67e-05	0.000187	CcSEcCtD
Haloperidol—Hypertension—Topiramate—epilepsy syndrome	1.67e-05	0.000187	CcSEcCtD
Haloperidol—Somnolence—Gabapentin—epilepsy syndrome	1.67e-05	0.000186	CcSEcCtD
Haloperidol—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.67e-05	0.000186	CcSEcCtD
Haloperidol—Dyspepsia—Gabapentin—epilepsy syndrome	1.65e-05	0.000185	CcSEcCtD
Haloperidol—Anxiety—Topiramate—epilepsy syndrome	1.64e-05	0.000183	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.63e-05	0.000183	CcSEcCtD
Haloperidol—Decreased appetite—Gabapentin—epilepsy syndrome	1.63e-05	0.000182	CcSEcCtD
Haloperidol—Urticaria—Pregabalin—epilepsy syndrome	1.63e-05	0.000182	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.62e-05	0.000181	CcSEcCtD
Haloperidol—Body temperature increased—Pregabalin—epilepsy syndrome	1.62e-05	0.000181	CcSEcCtD
Haloperidol—Dry mouth—Topiramate—epilepsy syndrome	1.61e-05	0.00018	CcSEcCtD
Haloperidol—Constipation—Gabapentin—epilepsy syndrome	1.6e-05	0.000179	CcSEcCtD
Haloperidol—Pruritus—Valproic Acid—epilepsy syndrome	1.6e-05	0.000179	CcSEcCtD
Haloperidol—Confusional state—Topiramate—epilepsy syndrome	1.59e-05	0.000178	CcSEcCtD
Haloperidol—Oedema—Topiramate—epilepsy syndrome	1.58e-05	0.000176	CcSEcCtD
Haloperidol—Diarrhoea—Valproic Acid—epilepsy syndrome	1.55e-05	0.000173	CcSEcCtD
Haloperidol—Nervous system disorder—Topiramate—epilepsy syndrome	1.55e-05	0.000173	CcSEcCtD
Haloperidol—Feeling abnormal—Gabapentin—epilepsy syndrome	1.55e-05	0.000173	CcSEcCtD
Haloperidol—Thrombocytopenia—Topiramate—epilepsy syndrome	1.55e-05	0.000173	CcSEcCtD
Haloperidol—Tachycardia—Topiramate—epilepsy syndrome	1.54e-05	0.000172	CcSEcCtD
Haloperidol—Skin disorder—Topiramate—epilepsy syndrome	1.53e-05	0.000171	CcSEcCtD
Haloperidol—Hyperhidrosis—Topiramate—epilepsy syndrome	1.53e-05	0.000171	CcSEcCtD
Haloperidol—Hypersensitivity—Pregabalin—epilepsy syndrome	1.51e-05	0.000169	CcSEcCtD
Haloperidol—Anorexia—Topiramate—epilepsy syndrome	1.5e-05	0.000168	CcSEcCtD
Haloperidol—Dizziness—Valproic Acid—epilepsy syndrome	1.5e-05	0.000167	CcSEcCtD
Haloperidol—Urticaria—Gabapentin—epilepsy syndrome	1.49e-05	0.000167	CcSEcCtD
Haloperidol—Body temperature increased—Gabapentin—epilepsy syndrome	1.48e-05	0.000166	CcSEcCtD
Haloperidol—Hypotension—Topiramate—epilepsy syndrome	1.47e-05	0.000165	CcSEcCtD
Haloperidol—Pruritus—Pregabalin—epilepsy syndrome	1.45e-05	0.000162	CcSEcCtD
Haloperidol—Vomiting—Valproic Acid—epilepsy syndrome	1.44e-05	0.000161	CcSEcCtD
Haloperidol—Insomnia—Topiramate—epilepsy syndrome	1.43e-05	0.00016	CcSEcCtD
Haloperidol—Rash—Valproic Acid—epilepsy syndrome	1.43e-05	0.00016	CcSEcCtD
Haloperidol—Dermatitis—Valproic Acid—epilepsy syndrome	1.43e-05	0.000159	CcSEcCtD
Haloperidol—Headache—Valproic Acid—epilepsy syndrome	1.42e-05	0.000158	CcSEcCtD
Haloperidol—Dyspnoea—Topiramate—epilepsy syndrome	1.41e-05	0.000157	CcSEcCtD
Haloperidol—Somnolence—Topiramate—epilepsy syndrome	1.4e-05	0.000157	CcSEcCtD
Haloperidol—Diarrhoea—Pregabalin—epilepsy syndrome	1.4e-05	0.000156	CcSEcCtD
Haloperidol—Dyspepsia—Topiramate—epilepsy syndrome	1.39e-05	0.000155	CcSEcCtD
Haloperidol—Hypersensitivity—Gabapentin—epilepsy syndrome	1.38e-05	0.000155	CcSEcCtD
Haloperidol—Decreased appetite—Topiramate—epilepsy syndrome	1.37e-05	0.000153	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.36e-05	0.000152	CcSEcCtD
Haloperidol—Dizziness—Pregabalin—epilepsy syndrome	1.35e-05	0.000151	CcSEcCtD
Haloperidol—Constipation—Topiramate—epilepsy syndrome	1.35e-05	0.000151	CcSEcCtD
Haloperidol—Nausea—Valproic Acid—epilepsy syndrome	1.34e-05	0.00015	CcSEcCtD
Haloperidol—Pruritus—Gabapentin—epilepsy syndrome	1.33e-05	0.000148	CcSEcCtD
Haloperidol—Vomiting—Pregabalin—epilepsy syndrome	1.3e-05	0.000145	CcSEcCtD
Haloperidol—Feeling abnormal—Topiramate—epilepsy syndrome	1.3e-05	0.000145	CcSEcCtD
Haloperidol—Rash—Pregabalin—epilepsy syndrome	1.29e-05	0.000144	CcSEcCtD
Haloperidol—Dermatitis—Pregabalin—epilepsy syndrome	1.29e-05	0.000144	CcSEcCtD
Haloperidol—Diarrhoea—Gabapentin—epilepsy syndrome	1.28e-05	0.000143	CcSEcCtD
Haloperidol—Headache—Pregabalin—epilepsy syndrome	1.28e-05	0.000143	CcSEcCtD
Haloperidol—Urticaria—Topiramate—epilepsy syndrome	1.25e-05	0.00014	CcSEcCtD
Haloperidol—Body temperature increased—Topiramate—epilepsy syndrome	1.25e-05	0.000139	CcSEcCtD
Haloperidol—Dizziness—Gabapentin—epilepsy syndrome	1.24e-05	0.000139	CcSEcCtD
Haloperidol—Nausea—Pregabalin—epilepsy syndrome	1.22e-05	0.000136	CcSEcCtD
Haloperidol—Vomiting—Gabapentin—epilepsy syndrome	1.19e-05	0.000133	CcSEcCtD
Haloperidol—Rash—Gabapentin—epilepsy syndrome	1.18e-05	0.000132	CcSEcCtD
Haloperidol—Dermatitis—Gabapentin—epilepsy syndrome	1.18e-05	0.000132	CcSEcCtD
Haloperidol—Headache—Gabapentin—epilepsy syndrome	1.18e-05	0.000131	CcSEcCtD
Haloperidol—Hypersensitivity—Topiramate—epilepsy syndrome	1.16e-05	0.00013	CcSEcCtD
Haloperidol—Pruritus—Topiramate—epilepsy syndrome	1.12e-05	0.000125	CcSEcCtD
Haloperidol—Nausea—Gabapentin—epilepsy syndrome	1.11e-05	0.000125	CcSEcCtD
Haloperidol—Diarrhoea—Topiramate—epilepsy syndrome	1.08e-05	0.000121	CcSEcCtD
Haloperidol—Dizziness—Topiramate—epilepsy syndrome	1.04e-05	0.000117	CcSEcCtD
Haloperidol—Vomiting—Topiramate—epilepsy syndrome	1e-05	0.000112	CcSEcCtD
Haloperidol—Rash—Topiramate—epilepsy syndrome	9.95e-06	0.000111	CcSEcCtD
Haloperidol—Dermatitis—Topiramate—epilepsy syndrome	9.94e-06	0.000111	CcSEcCtD
Haloperidol—Headache—Topiramate—epilepsy syndrome	9.89e-06	0.000111	CcSEcCtD
Haloperidol—Nausea—Topiramate—epilepsy syndrome	9.37e-06	0.000105	CcSEcCtD
Haloperidol—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	8.17e-07	1.5e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	8.16e-07	1.5e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.16e-07	1.5e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TH—epilepsy syndrome	8.14e-07	1.49e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	8.13e-07	1.49e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	8.12e-07	1.49e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—BCHE—epilepsy syndrome	8.09e-07	1.48e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	8.08e-07	1.48e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	8.04e-07	1.47e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GPX1—epilepsy syndrome	8.04e-07	1.47e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.02e-07	1.47e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—POMC—epilepsy syndrome	8.01e-07	1.47e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	7.99e-07	1.47e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NGF—epilepsy syndrome	7.95e-07	1.46e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.91e-07	1.45e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—POMC—epilepsy syndrome	7.9e-07	1.45e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.9e-07	1.45e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.9e-07	1.45e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.9e-07	1.45e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FGF2—epilepsy syndrome	7.86e-07	1.44e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	7.83e-07	1.44e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	7.82e-07	1.43e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NGF—epilepsy syndrome	7.81e-07	1.43e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	7.78e-07	1.43e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	7.78e-07	1.43e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	7.73e-07	1.42e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	7.73e-07	1.42e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.72e-07	1.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.7e-07	1.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TH—epilepsy syndrome	7.67e-07	1.41e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.63e-07	1.4e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	7.61e-07	1.4e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TH—epilepsy syndrome	7.61e-07	1.39e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	7.59e-07	1.39e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GPX1—epilepsy syndrome	7.59e-07	1.39e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	7.58e-07	1.39e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	7.57e-07	1.39e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	7.51e-07	1.38e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.49e-07	1.37e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ALB—epilepsy syndrome	7.48e-07	1.37e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	7.43e-07	1.36e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	7.43e-07	1.36e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	7.42e-07	1.36e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.31e-07	1.34e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RELA—epilepsy syndrome	7.3e-07	1.34e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	7.29e-07	1.34e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	7.28e-07	1.33e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	7.19e-07	1.32e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AGT—epilepsy syndrome	7.18e-07	1.32e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	7.16e-07	1.31e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	7.08e-07	1.3e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	7.08e-07	1.3e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	7.07e-07	1.3e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	7.06e-07	1.29e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AGT—epilepsy syndrome	7.05e-07	1.29e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AGT—epilepsy syndrome	7.05e-07	1.29e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APOE—epilepsy syndrome	7.04e-07	1.29e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	6.99e-07	1.28e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	6.97e-07	1.28e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	6.96e-07	1.28e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	6.94e-07	1.27e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	6.92e-07	1.27e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	6.91e-07	1.27e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APOE—epilepsy syndrome	6.91e-07	1.27e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—APOE—epilepsy syndrome	6.9e-07	1.27e-05	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	6.9e-07	1.26e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KDR—epilepsy syndrome	6.89e-07	1.26e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CAT—epilepsy syndrome	6.87e-07	1.26e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	6.83e-07	1.25e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	6.83e-07	1.25e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	6.8e-07	1.25e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	6.78e-07	1.24e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KDR—epilepsy syndrome	6.77e-07	1.24e-05	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.75e-07	1.24e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CAT—epilepsy syndrome	6.7e-07	1.23e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	6.69e-07	1.23e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	6.68e-07	1.23e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AGT—epilepsy syndrome	6.66e-07	1.22e-05	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	6.65e-07	1.22e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	6.64e-07	1.22e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	6.64e-07	1.22e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	6.61e-07	1.21e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	6.59e-07	1.21e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	6.59e-07	1.21e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RELA—epilepsy syndrome	6.57e-07	1.2e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	6.54e-07	1.2e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.53e-07	1.2e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	6.52e-07	1.2e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—APOE—epilepsy syndrome	6.52e-07	1.2e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	6.52e-07	1.19e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.5e-07	1.19e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	6.5e-07	1.19e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TH—epilepsy syndrome	6.5e-07	1.19e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	6.49e-07	1.19e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RELA—epilepsy syndrome	6.48e-07	1.19e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	6.46e-07	1.18e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	6.45e-07	1.18e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.44e-07	1.18e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.4e-07	1.17e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.4e-07	1.17e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—JUN—epilepsy syndrome	6.4e-07	1.17e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	6.36e-07	1.17e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.35e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.34e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	6.32e-07	1.16e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.32e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	6.29e-07	1.15e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.27e-07	1.15e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	6.26e-07	1.15e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.26e-07	1.15e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.24e-07	1.14e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	6.22e-07	1.14e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	6.21e-07	1.14e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.15e-07	1.13e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	6.13e-07	1.12e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	6.11e-07	1.12e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.09e-07	1.12e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.06e-07	1.11e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—POMC—epilepsy syndrome	6.05e-07	1.11e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	6.04e-07	1.11e-05	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.98e-07	1.1e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	5.95e-07	1.09e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	5.95e-07	1.09e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	5.94e-07	1.09e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—epilepsy syndrome	5.94e-07	1.09e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—epilepsy syndrome	5.93e-07	1.09e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	5.93e-07	1.09e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	5.91e-07	1.08e-05	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	5.9e-07	1.08e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	5.85e-07	1.07e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	5.83e-07	1.07e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	5.82e-07	1.07e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	5.81e-07	1.06e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	5.8e-07	1.06e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	5.76e-07	1.06e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—JUN—epilepsy syndrome	5.76e-07	1.06e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SRC—epilepsy syndrome	5.74e-07	1.05e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.71e-07	1.05e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—JUN—epilepsy syndrome	5.68e-07	1.04e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	5.68e-07	1.04e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.66e-07	1.04e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.63e-07	1.03e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—epilepsy syndrome	5.6e-07	1.03e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	5.6e-07	1.03e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	5.59e-07	1.02e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	5.53e-07	1.01e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	5.48e-07	1e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AGT—epilepsy syndrome	5.45e-07	9.99e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	5.43e-07	9.96e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.42e-07	9.94e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—epilepsy syndrome	5.41e-07	9.91e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	5.36e-07	9.83e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.36e-07	9.82e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.35e-07	9.81e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	5.35e-07	9.8e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—epilepsy syndrome	5.34e-07	9.78e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.34e-07	9.78e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.33e-07	9.78e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AGT—epilepsy syndrome	5.32e-07	9.75e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	5.26e-07	9.64e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	5.25e-07	9.62e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—epilepsy syndrome	5.21e-07	9.55e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.21e-07	9.54e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SRC—epilepsy syndrome	5.17e-07	9.47e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—epilepsy syndrome	5.11e-07	9.36e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SRC—epilepsy syndrome	5.1e-07	9.34e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.09e-07	9.33e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.03e-07	9.23e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.03e-07	9.22e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TH—epilepsy syndrome	5.02e-07	9.2e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.01e-07	9.18e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.97e-07	9.11e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	4.96e-07	9.1e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RELA—epilepsy syndrome	4.96e-07	9.1e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.91e-07	9e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	4.88e-07	8.95e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.87e-07	8.93e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—epilepsy syndrome	4.87e-07	8.92e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	4.87e-07	8.92e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.84e-07	8.87e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	4.79e-07	8.78e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	4.78e-07	8.76e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	4.73e-07	8.67e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—epilepsy syndrome	4.59e-07	8.41e-06	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.52e-07	8.28e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	4.48e-07	8.21e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—epilepsy syndrome	4.48e-07	8.2e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	4.47e-07	8.19e-06	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.44e-07	8.15e-06	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.44e-07	8.13e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	4.4e-07	8.07e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	4.39e-07	8.06e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JUN—epilepsy syndrome	4.35e-07	7.97e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	4.28e-07	7.84e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JUN—epilepsy syndrome	4.27e-07	7.83e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.24e-07	7.78e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	4.23e-07	7.75e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.22e-07	7.73e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.19e-07	7.67e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.18e-07	7.66e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—epilepsy syndrome	4.18e-07	7.66e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-07	7.63e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.16e-07	7.62e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	4.15e-07	7.61e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.13e-07	7.57e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	4.1e-07	7.52e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—epilepsy syndrome	4.08e-07	7.48e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-07	7.4e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.03e-07	7.38e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.02e-07	7.37e-06	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—epilepsy syndrome	3.91e-07	7.17e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SRC—epilepsy syndrome	3.9e-07	7.15e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.84e-07	7.05e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	3.84e-07	7.03e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.83e-07	7.02e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.81e-07	6.99e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	3.8e-07	6.96e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-07	6.85e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.74e-07	6.85e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.73e-07	6.84e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	3.7e-07	6.78e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	3.66e-07	6.7e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	3.62e-07	6.64e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.57e-07	6.55e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.57e-07	6.54e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	3.57e-07	6.54e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	3.4e-07	6.24e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.36e-07	6.17e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.33e-07	6.11e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—epilepsy syndrome	3.29e-07	6.03e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.28e-07	6.01e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.26e-07	5.97e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.21e-07	5.88e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.21e-07	5.88e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	3.17e-07	5.81e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.85e-07	5.22e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.76e-07	5.05e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.51e-07	4.61e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.42e-07	4.44e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-07	4.37e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-07	4.36e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.38e-07	4.36e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—epilepsy syndrome	2.25e-07	4.12e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.2e-07	4.03e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.84e-07	3.37e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.79e-07	3.29e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.69e-07	3.1e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.68e-07	3.07e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.43e-07	2.63e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.11e-07	2.03e-06	CbGpPWpGaD
